Dysfunction of the
ubiquitin-
proteasome system (UPS) and
calcium homeostasis has been implicated in the neurodegeneration of Alzheimer's and Parkinson's diseases. The cytosolic
calcium concentration is maintained by store-operated
calcium entry (SOCE), which is repressed by
Alzheimer's disease-associated mutants, such as mutant
presenilins. We hypothesized that inhibition of UPS impacts SOCE. This study showed that pretreatment with sub-lethal levels of
proteasome inhibitors, including
MG-132 and clasto-
lactacystin-β-
lactone (LA), reduced SOCE after depletion of endoplasmic reticulum
calcium in rat neurons. With the same treatment,
MG-132 and LA reduced the
protein levels of
stromal interaction molecule 1and 2 (STIM1/2), but not the levels of Orai1 and canonical
transient receptor potential channel 1 (TRPC1). STIM1 or
STIM2 protein was mobilized to lysosome by
MG-132/LA treatment as observed under an immunofluorescence confocal
laser microscope. In the neurons,
MG-132 and LA degraded p62/SQSTM1, promoted autophagy, converted LC3I to LC3II, and promoted co-localization of LC3 and lysosomes.
Rapamycin, which enhances autophagy, reduced STIM1/2
protein levels, whereas bafilomycin, which inhibits autophagy, increased their
protein levels. The
protein levels of STIM1/2 and the amplitude of SOCE were decreased in SH-SY5Y with decreased
protein level of
proteasome subunit beta type-5 induced by
shRNA. We conclude that sub-lethal levels of
proteasome inhibition reduce SOCE and promote autophagy-mediated degradation of STIM1/2. UPS inhibition, a common finding in
neurodegenerative diseases, interferes with
calcium homeostasis via repression of SOCE.